| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antitumor efficacy of CHMFL-KIT-110 solid dispersion in mouse xenograft models of human gastrointestinal stromal tumors
|
Wang, Shengfu
|
|
|
88 |
5 |
p. 795-804
|
artikel
|
| 2 |
A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors
|
Liao, Mingxiang
|
|
|
88 |
5 |
p. 887-897
|
artikel
|
| 3 |
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, pharmacokinetics, and immunogenicity of a combined infusion of ABP 980 and pertuzumab in healthy subjects
|
Hanes, Vladimir
|
|
|
88 |
5 |
p. 879-886
|
artikel
|
| 4 |
Association between glucose intolerance and chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease
|
Otani, Toshihito
|
|
|
88 |
5 |
p. 857-865
|
artikel
|
| 5 |
A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes
|
van Kan, Maia
|
|
|
88 |
5 |
p. 755-769
|
artikel
|
| 6 |
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck
|
Göksu, Sema Sezgin
|
|
|
88 |
5 |
p. 805-812
|
artikel
|
| 7 |
Comment on “Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase”
|
Tong, Wing H.
|
|
|
88 |
5 |
p. 919-920
|
artikel
|
| 8 |
Covariate effects and population pharmacokinetic analysis of the anti-FGFR2b antibody bemarituzumab in patients from phase 1 to phase 2 trials
|
Xiang, Hong
|
|
|
88 |
5 |
p. 899-910
|
artikel
|
| 9 |
Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian Amazon
|
Fernandes, Marianne Rodrigues
|
|
|
88 |
5 |
p. 837-844
|
artikel
|
| 10 |
Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study
|
Toksvang, Linea Natalie
|
|
|
88 |
5 |
p. 911-917
|
artikel
|
| 11 |
Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models
|
Terterov, Ivan N.
|
|
|
88 |
5 |
p. 867-878
|
artikel
|
| 12 |
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment
|
Akce, Mehmet
|
|
|
88 |
5 |
p. 825-836
|
artikel
|
| 13 |
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy
|
Duran, Goretti
|
|
|
88 |
5 |
p. 813-823
|
artikel
|
| 14 |
Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells
|
Huot, Marielle
|
|
|
88 |
5 |
p. 845-856
|
artikel
|
| 15 |
The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
|
Torki, Zahra
|
|
|
88 |
5 |
p. 771-793
|
artikel
|
Tijdschrift beschrijving